1. Development and validation of a highly sensitive and robust LC–ESI-MS/MS method for simultaneous quantitation of simvastatin acid, amlodipine and valsartan in human plasma: application to a clinical pharmacokinetic study;Ramani;Biomed. Chromatogr.,2009
2. Valsartan/hydrochlorothiazide: a review of its pharmacology, therapeutic efficacy and place in the management of hypertension;Wellington;Drugs,2002
3. Crystal Phend, Staff Writer, FDA Approves Triple-Drug Antihypertensive Polypill, MedPageToday,Washington, (〈http://www.medpagetoday.com/ProductAlert/Prescriptions/14032〉), May 1 2009.
4. Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research(CDER), Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) Tablets, (〈http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm262227.htm〉), 2012.
5. H.C.T. Exforge, Rx List, (〈http://www.rxlist.com/exforge-hct-drug.htm〉), September 18 2013.